Attenuation of N-Nitrosodiethylamine -Induced Hepatocellular Carcinoma by Piceatannol and/or Cisplatin: The Interplay between Nuclear Factor (Erythroid Derived 2)-like 2 and Redox Status

Volume 23, Issue 11, November 2022, Pages 3895-3903

Omnia AM Salama; Fatma SM Moawed; Enas M Moustafa; Eman I Kandil

• View Article
• PDF 957.57 K

The Role of Genetic Polymorphisms in Nrf2 and P73 in Egyptian Women with Breast Cancer

Volume 17, Issue 11, November 2016, Pages 4945-4949

Nevin M Al Azhary; Mahmoud M Kamel; Yahia M Ismail; Amal A Mahmoud; Enas M Radwan

• View Article
• PDF 369.29 K

Luteolin, a Bioflavonoid Inhibits Colorectal Cancer through Modulation of Multiple Signaling Pathways: A Review

Volume 15, Issue 14, December 2014, Pages 5501-5508

• View Article
• PDF 596.84 K

Luteolin-loaded Phytosomes Sensitize Human Breast Carcinoma MDA-MB 231 Cells to Doxorubicin by Suppressing Nrf2 Mediated Signalling

Volume 15, Issue 13, December 2014, Pages 5311-5316

• View Article
• PDF 992.75 K

miR-340 Reverses Cisplatin Resistance of Hepatocellular Carcinoma Cell Lines by Targeting Nrf2-dependent Antioxidant Pathway

Volume 15, Issue 23, December 2014, Pages 10439-10444

• View Article
• PDF 1.55 M

Luteolin Sensitizes Two Oxaliplatin-Resistant Colorectal Cancer Cell Lines to Chemotherapeutic Drugs Via Inhibition of the Nrf2 Pathway

Volume 15, Issue 6, June 2014, Pages 2911-2916

• View Article
• PDF 568.2 K

Association of NRF2 Polymorphism with Cholangiocarcinoma Prognosis in Thai Patients

Volume 15, Issue 1, January 2014, Pages 299-304

• View Article
• PDF 543.18 K

Dietary Non-nutritive Factors in Targeting of Regulatory Molecules in Colorectal Cancer: An Update

Volume 14, Issue 10, October 2013, Pages 5543-5552

• View Article
• PDF 796.09 K

Nrf2 Overexpression Predicts Prognosis and 5-FU Resistance in Gastric Cancer

Volume 14, Issue 9, September 2013, Pages 5231-5235

• View Article
• PDF 1.28 M